Short-chain carboxylic acid concentration in human gingival crevicular fluid

Journal of Dental Research

Volumn 76, Issue 1, 1997, Pages 575-579

  Niederman, R ^a,b   Buyle Bodin, Y ^c   Lu, B Y ^c   Robinson, P ^c   Naleway, C ^d  

^a FORSYTH INSTITUTE   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d AMERICAN DENTAL ASSOCIATION   (United States)

Author keywords

Butyric acid; Periodontal disease; Propionic acid; Short chain carboxylic acids

Indexed keywords

BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; PROPIONIC ACID; PROPIONIC ACID DERIVATIVE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL COUNT; CAMPYLOBACTER; CHEMISTRY; EIKENELLA CORRODENS; FUSOBACTERIUM NUCLEATUM; GINGIVITIS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; NONPARAMETRIC TEST; PERIODONTICS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; TREPONEMA;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; BUTYRIC ACID; BUTYRIC ACIDS; CAMPYLOBACTER; COLONY COUNT, MICROBIAL; EIKENELLA CORRODENS; FUSOBACTERIUM NUCLEATUM; GINGIVAL CREVICULAR FLUID; HUMANS; PERIODONTAL INDEX; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PROPIONIC ACIDS; STATISTICS, NONPARAMETRIC; TREPONEMA;

EID: 0030636714     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/00220345970760010801     Document Type: Article

References (38)

1. Adams SS (1992). The propionic acids: a personal perspective. J Clin Pharm 32:317-323.
2. Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S (1987). Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1:14-16.
3. Botta GA, Radin L, Costa A, Schito G, Blasi G (1985). Gas-liquid chromatography of the gingival fluid as an aid in periodontal diagnosis. J Periodont Res 20:450-457.
4. Brewer GJ, Yuzbasiyan-Gurkan V, Lee DY (1990). Use of zinc-copper metabolic interactions in the treatment of Wilson's disease. J Am Coll Nutrition 9:487-491.
5. Brunkhorst BA, Kraus E, Coppi M, Budnick M, Niederman R (1992). Propionate induces polymorphonuclear leukocyte activation and inhibits formyl-methionyl-leucyl-phenylalanine-stimulated activation. Infect Immun 60:2957-2968.
6. Courtois P, Labbé M, Pourtois M, Mandelbaum IM (1989). Anaerobes and short-chain fatty acids in crevicular fluid from adults with chronic periodontitis. Bull Groupe Int Rech Scientif Stomat 32:19-22.
7. Eftimiadi C, Buzzi E, Tonetti M, Buffa P, Buffa D, van Steenbergen TM, et al. (1987). Short-chain fatty acids produced by anaerobic bacteria alter the physiological responses of human neutrophils to chemotactic peptide. J Infect 14:43-53.
8. Eftimiadi C, Tonetti M, Cavallero A, Sacco O, Rossi GA (1990). Short-chain fatty acids produced by anaerobic bacteria inhibit phagocytosis by human lung phagocytes. J Infect Dis 161:138-141.
9. Eftimiadi C, Stashenko P, Tonetti M, Mangiante PE, Massara R, Zupo S, et al. (1991). Divergent effect of the anaerobic bacteria by-product butyric acid on the immune response: suppression of T-lymphocyte proliferation and stimulation of interleukin-1 beta production. Oral Microbiol Immunol 6:17-23.
10. Eftimiadi C, Valente S, Mangiante S, Mangiante PE, Niederman R (1993). Short chain fatty acids produced by anaerobic bacteria inhibit adhesion and proliferation of periodontal ligament fibroblasts. Minerva Stomatol 42:481-485.
11. Haffajee AD, Socransky SS (1994). Microbial etiological agents of destructive periodontal diseases. Periodontology 2000 5:78-111.
12. Harrison PT (1992). Propionic acid and the phenomenon of rodent forestomach tumorigenesis: a review. Food & Chem Tox 30:333-340.
13. Holdeman LV, Catok EP, Moore WEC, editors (1977). Anaerobe laboratory manual. 4th ed. Blacksburg, VA: Virginia Polytechnic Institute and State University.
14. Kraus E, Niederman R (1990). Changes in neutrophil right-angle light scatter can occur independently of alterations in cytoskeletal actin. Cytometry 11:272-282.
15. Kurita-Ochiai T, Fukushima K, Ochiai K (1995). Volatile fatty acids, metabolic by-products of periodontopathic bacteria, inhibit lymphocyte proliferation and cytokine production. J Dent Res 74:1367-1373.
16. Lanza FL (1993). Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 88:1318-1323.
17. Leppik IE (1994). Antiepileptic drugs in development: prospects for the near future. Epilepsia 35(Suppl 4):S29-S40.
18. Liesivuori J, Savolainen H (1991). Methanol and formic acid toxicity: biochemical mechanisms. Pharm & Tox 69:157-163.
19. Mollinedo F, Gajate C, Tugores A, Flores I, Naranjo JR (1993). Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes. Biochem J 294:137-144.
20. 2+ in resting and stimulated human neutrophils by short-chain carboxylic acids at neutral pH. Infect Immun 60:5307-5311.
21. Newmark HL, Lupton JR, Young CW (1994). Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. Cancer Lett 78:1-5.
22. Niederman R, Naleway C, Lu B-Y, Buyle-Bodin Y, Robinson P (1995). Subgingival temperature as a gingival inflammatory indicator. J Clin Periodontol 22:804-809.
23. Niederman R, Zhang J, Kashket S (1996). Short chain carboxylic acid mediated gingival inflammation. Crit Rev Oral Biol Med (in press).
24. Perrine SP, Dover GH, Daftari P, Walsh CT, Jin Y, Mays A, et al. (1994). Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo. Br J Haem 88:555-561.
25. Rius C, Vilaboa N, Mata F, Aller P (1993). Differential modulation of the expression of the intermediate filament proteins vimentin and nuclear lamins A and C by differentiation inducers in human myeloid leukemia (U-937, HL-60) cells. Exp Cell Res 208:115-120.
26. Rotstein OD, Pruett TL, Fiegel VD, Nelson RD, Simmons R (1985). Succinic acid, a metabolic by-product of Bacteroides species, inhibits polymorphonuclear leukocyte function. Infect Immun 48:402-408.
27. Rotstein OD, Nasmith PE, Grinstein S (1987). The Bacteroides by-product succinic acid inhibits neutrophil respiratory burst by reducing intracellular pH. Infect Immun 55:864-870.
28. Rotstein OD, Vittorini T, Kao J, McBurney MI, Nasmith PE, Grinstein S (1989). A soluble Bacteroides by-product impairs phagocyte killing of Escherichia coli by neutrophils. Infect Immun 57:745-753.
29. Singer RE, Buckner BA (1981). Butyrate, propionate: Important components of toxic dental plaque extracts. Infect Immun 32:458-463.
30. Singer RE, Buckner BA, Meckel AL, Leonard GJ (1980). Propionate and butyrate induction of gingival inflammation in the beagle (abstract). J Dent Res 59:230.
31. Stacpoole PW (1989). The pharmacology of dichloroacetate. Metab Clin Exp 38:1124-1144.
32. Stringer RE, Hart CA, Edwards SW (1996). Sodium butyrate delays neutrophil apoptosis: role of protein biosynthesis in neutrophil survival. Br J Haematol 92:169-175.
33. Swartwout S, Niederman R (1996). Bacterial metabolite mediated differential human PMN gene expression. J Periodont Res (in press).
34. Tonetti M, Budnick M, Niederman R (1990). Receptor-stimulated actin polymerization requires cytoplasmic acidification in human PMNs. Biochim Biophys Acta 1054:154-158.
35. Tonetti M, Cavallero A, Botta GA, Niederman R, Eftimiadi C (1991). Intracellular pH regulates the production of different oxygen metabolites in neutrophils: effects of organic acids produced by anaerobic bacteria. J Leukocyte Biol 49:180-188.
36. Tse CS, Williams DM (1992). Inhibition of human endothelial cell proliferation in vitro in response to n-butyrate and propionate. J Periodont Res 27:506-510.
37. White DJ, Cox E, Gwynn AV (1995). Effect of stabilized stannous fluoride dentifrice on plaque acid (toxin) production. J Clin Dent 6:84-88.
38. Zhang J (1996). Gingival inflammation induced by food and short chain carboxylic acids (DMSc thesis). Cambridge, MA: Harvard University.